Webinar: State of the Art in Clinical Transporter DDI Evaluation
Thursday, June 13, 2019
11:30am – 12:30pm EDT
State of the Art in Clinical Transporter DDI Evaluation
This presentation summarized the state-of-the-art in transporters in drug development based on four recent ITC3 whitepapers (Clin Pharmacol Ther 104, October 2018).
- Transporters in drug development based on four recent ITC3 whitepapers
- Overview of emerging transporters of clinical relevance
- Best practice in design of clinical DDI studies through recent advances
- Consideration for optimal selection of clinical probe drugs, including future potential utility of transporter biomarkers
Absorption Systems partnered with GSK to provide you with the most relevant and applicable research in Transporter DDI Evaluations
This presentation is based on the data highlighted in four recent publications by the International Transporter Consortium.
These four publications are available for download below:
Maciej J. Zamek-Gliszczynski, PhD
Senior Fellow and Director, DMPK, GlaxoSmithKline